{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:33:30Z","timestamp":1792784010115,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Department of Pathology and Department of Laboratory Medicine, Nationwide Children's Hospital, Columbus, Ohio.","id":[{"id":"https:\/\/ror.org\/003rfsp33","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jaci.2020.09.020","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T02:39:30Z","timestamp":1601433570000},"page":"532-544.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Severe SARS-CoV-2 disease in the context of a NF-\u03baB2 loss-of-function pathogenic variant"],"prefix":"10.1016","volume":"147","author":[{"given":"Roshini S.","family":"Abraham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna M.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Sun","family":"Kuehn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar M.","family":"Rueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Gibbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Will","family":"Guider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio D.","family":"Rosenzweig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophonie","family":"Jean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Peeples","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Garrett","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan R.","family":"Honegger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Octavio","family":"Ramilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Mustillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asuncion","family":"Mejias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica I.","family":"Ardura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Shimamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2020.09.020_bib1","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a000034","article-title":"The NF-kappaB family of transcription factors and its regulation","volume":"1","author":"Oeckinghaus","year":"2009","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.jaci.2020.09.020_bib2","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1007\/s00018-005-5031-5","article-title":"The NF-kappaB signaling pathway in human genetic diseases","volume":"62","author":"Courtois","year":"2005","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jaci.2020.09.020_bib3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2016.12.012","article-title":"30 Years of NF-kappaB: A\u00a0blossoming of relevance to human pathobiology","volume":"168","author":"Zhang","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2020.09.020_bib4","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.ajhg.2013.09.009","article-title":"Germline mutations in NFKB2 implicate the noncanonical NF-kappaB pathway in the pathogenesis of common variable immunodeficiency","volume":"93","author":"Chen","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jaci.2020.09.020_bib5","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3389\/fimmu.2019.00297","article-title":"Clinical and immunological phenotype of patients with primary immunodeficiency due to damaging mutations in NFKB2","volume":"10","author":"Klemann","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2020.09.020_bib6","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1182\/blood-2017-05-782177","article-title":"Novel nonsense gain-of-function NFKB2 mutations associated with a combined immunodeficiency phenotype","volume":"130","author":"Kuehn","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2020.09.020_bib7","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/ni.2072","article-title":"NF-kappaB is 25","volume":"12","author":"Baltimore","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2020.09.020_bib8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and Is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2020.09.020_bib9","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00127-20","article-title":"Receptor recognition by the novel coronavirus from wuhan: an analysis based on decade-long structural studies of SARS coronavirus","volume":"94","author":"Wan","year":"2020","journal-title":"J Virol"},{"key":"10.1016\/j.jaci.2020.09.020_bib10","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: immunity, inflammation and intervention","volume":"20","author":"Tay","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2020.09.020_bib11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3389\/fimmu.2017.00259","article-title":"Type I interferons as regulators of lung inflammation","volume":"8","author":"Makris","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2020.09.020_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002352","article-title":"Type 1 interferons and antiviral CD8 T-cell responses","volume":"8","author":"Welsh","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jaci.2020.09.020_bib13","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2 drives development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2020.09.020_bib14","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/s41418-020-0530-3","article-title":"COVID-19 infection: the perspectives on immune responses","volume":"27","author":"Shi","year":"2020","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jaci.2020.09.020_bib15","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.immuni.2020.05.002","article-title":"Immunology of COVID-19: current state of the science","volume":"52","author":"Vabret","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2020.09.020_bib16","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/j.jaip.2020.04.014","article-title":"Weathering the cytokine storm in susceptible patients with severe SARS-CoV-2 infection","volume":"8","author":"Lipworth","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2020.09.020_bib17","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.healun.2020.03.012","article-title":"COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal","volume":"39","author":"Siddiqi","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jaci.2020.09.020_bib18","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/infdis\/jiaa150","article-title":"Characteristics of peripheral lymphocyte subset\u00a0alteration in COVID-19 pneumonia","volume":"221","author":"Wang","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaci.2020.09.020_bib19","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jaci.2020.04.013","article-title":"A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia","volume":"146","author":"Quinti","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.09.020_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abd0110","article-title":"Inhibition of Bruton tyrosine kinase in patients with severe COVID-19","volume":"5","author":"Roschewski","year":"2020","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2020.09.020_bib21","article-title":"Coronavirus disease 2019 in patients with inborn errors of immunity: an international study","author":"Meyts","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.09.020_bib22","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1182\/blood-2014-06-578542","article-title":"Autosomal-dominant B-cell deficiency with alopecia due to a mutation in NFKB2 that results in nonprocessable p100","volume":"124","author":"Lee","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2020.09.020_bib23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s12881-014-0139-9","article-title":"Mutations in NFKB2 and potential genetic heterogeneity in patients with DAVID syndrome, having variable endocrine and immune deficiencies","volume":"15","author":"Brue","year":"2014","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.jaci.2020.09.020_bib24","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.jaci.2014.11.038","article-title":"Defective natural killer-cell cytotoxic activity in NFKB2-mutated CVID-like disease","volume":"135","author":"Lougaris","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.09.020_bib25","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1172\/JCI138554","article-title":"Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent","volume":"130","author":"Mazzoni","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2020.09.020_bib26","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/s41591-020-0944-y","article-title":"A single-cell atlas of the peripheral immune response in patients with severe COVID-19","volume":"26","author":"Wilk","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2020.09.020_bib27","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41423-020-0402-2","article-title":"Functional exhaustion of antiviral lymphocytes in COVID-19 patients","volume":"17","author":"Zheng","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jaci.2020.09.020_bib28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1600-065X.2011.01091.x","article-title":"Dimer-specific regulatory mechanisms within the NF-kappaB family of transcription factors","volume":"246","author":"Smale","year":"2012","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2020.09.020_bib29","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/cr.2010.161","article-title":"A single NFkappaB system for both canonical and non-canonical signaling","volume":"21","author":"Shih","year":"2011","journal-title":"Cell Res"},{"key":"10.1016\/j.jaci.2020.09.020_bib30","doi-asserted-by":"crossref","unstructured":"Joyner M, Wright RS, Fairweather D, Senefeld J, Bruno K, Klassen S, et\u00a0al. Early safety indicators of COVID-19 convalescent plasma in 5,000 patients [e-pub ahead of print]. medRxiv https:\/\/doi.org\/10.1101\/2020.05.12.20099879. Accessed June 19, 2020.","DOI":"10.1101\/2020.05.12.20099879"},{"key":"10.1016\/j.jaci.2020.09.020_bib31","doi-asserted-by":"crossref","unstructured":"Quartuccio L, Sonaglia A, Pecori D, Peghin M, Fabris M, Tascini C, et\u00a0al. Higher levels of IL-6 early after tocilizumab distinguish survivors from nonsurvivors in COVID-19 pneumonia: a possible indication for deeper targeting of IL-6. J Med Virol https:\/\/doi.org\/10.1002\/jmv.26149. Accessed August 11, 2020.","DOI":"10.1002\/jmv.26149"},{"key":"10.1016\/j.jaci.2020.09.020_bib32","doi-asserted-by":"crossref","first-page":"E121","DOI":"10.1210\/jc.2011-0407","article-title":"Deficit in anterior pituitary function and variable immune deficiency (DAVID) in children presenting with adrenocorticotropin deficiency and severe infections","volume":"97","author":"Quentien","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jaci.2020.09.020_bib33","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.jaci.2017.11.014","article-title":"Anticytokine autoantibodies in a patient with a heterozygous NFKB2 mutation","volume":"141","author":"Ramakrishnan","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.09.020_bib34","doi-asserted-by":"crossref","first-page":"5360","DOI":"10.1038\/ncomms6360","article-title":"Biallelic loss-of-function mutation in NIK causes a primary immunodeficiency with multifaceted aberrant lymphoid immunity","volume":"5","author":"Willmann","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2020.09.020_bib35","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1056\/NEJMoa2007016","article-title":"Compassionate use of remdesivir for patients with severe Covid-19","volume":"382","author":"Grein","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2020.09.020_bib36","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41591-020-0819-2","article-title":"Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19","volume":"26","author":"Thevarajan","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2020.09.020_bib37","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2020.09.020_bib38","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/cid\/ciaa248","article-title":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China","volume":"71","author":"Qin","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaci.2020.09.020_bib39","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jaci.2020.05.008","article-title":"Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19","volume":"146","author":"Herold","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.09.020_bib40","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/jmv.25801","article-title":"Tocilizumab treatment in COVID-19: a single center experience","volume":"92","author":"Luo","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.jaci.2020.09.020_bib41","doi-asserted-by":"crossref","first-page":"10970","DOI":"10.1073\/pnas.2005615117","article-title":"Effective treatment of severe COVID-19 patients with tocilizumab","volume":"117","author":"Xu","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2020.09.020_bib42","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1182\/blood-2014-05-552729","article-title":"Current concepts in the diagnosis and management of cytokine release syndrome","volume":"124","author":"Lee","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2020.09.020_bib43","doi-asserted-by":"crossref","unstructured":"Vultaggio A, Vivarelli E, Virgili G, Lucenteforte E, Bartoloni A, Nozzoli C, et\u00a0al. Prompt predicting of early clinical deterioration of moderate-to-severe COVID-19 patients: usefulness of a combined score using IL-6 in a preliminary study [e-pub ahead of print]. J Allergy Clin Immunol Pract https:\/\/doi.org\/10.1016\/j.jaip.2020.06.013. Accessed August 15, 2020.","DOI":"10.1016\/j.jaip.2020.06.013"},{"key":"10.1016\/j.jaci.2020.09.020_bib44","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1182\/blood-2008-05-155846","article-title":"Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease","volume":"112","author":"Nishimoto","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2020.09.020_bib45","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.7150\/ijbs.4989","article-title":"IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6","volume":"8","author":"Rose-John","year":"2012","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.jaci.2020.09.020_bib46","doi-asserted-by":"crossref","unstructured":"Knight V, Long T, Meng QH, Linden MA, Rhoads DD. Variability in the laboratory measurement of cytokines: a longitudinal summary of a College of American Pathologists proficiency testing survey [e-pub ahead of print]. Arch Pathol Lab Med https:\/\/doi.org\/10.5858\/arpa.2019-0519-CP. Accessed May 10, 2020.","DOI":"10.5858\/arpa.2019-0519-CP"},{"key":"10.1016\/j.jaci.2020.09.020_bib47","first-page":"325","article-title":"Heterophile antibody interference in a multiplexed fluorescent microsphere immunoassay for quantitation of cytokines in human serum","volume":"11","author":"Martins","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.jaci.2020.09.020_bib48","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1172\/JCI138003","article-title":"The convalescent sera option for containing COVID-19","volume":"130","author":"Casadevall","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2020.09.020_bib49","doi-asserted-by":"crossref","first-page":"9490","DOI":"10.1073\/pnas.2004168117","article-title":"Effectiveness of convalescent plasma therapy in severe COVID-19 patients","volume":"117","author":"Duan","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2020.09.020_bib50","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/jama.2020.4783","article-title":"Treatment of 5 critically ill patients with COVID-19 with convalescent plasma","volume":"323","author":"Shen","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2020.09.020_bib51","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41586-020-2456-9","article-title":"Convergent antibody responses to SARS-CoV-2 in convalescent individuals","volume":"584","author":"Robbiani","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2020.09.020_bib52","doi-asserted-by":"crossref","unstructured":"Vandergaast R, Carey T, Reiter S, Lech P, Gnanadurai C, Tesfay M, et\u00a0al. Development and validation of IMMUNO-COV: a high-throughput clinical assay for detecting antibodies that neutralize SARS-CoV-2 [e-pub ahead of print]. bioRxiv https:\/\/doi.org\/10.1101\/2020.05.26.117549. Accessed June 12, 2020.","DOI":"10.1101\/2020.05.26.117549"},{"key":"10.1016\/j.jaci.2020.09.020_bib53","doi-asserted-by":"crossref","unstructured":"Braun J, Loyal L, Frentsch M, Wendisch D, Georg P, Kurth F, et\u00a0al. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19 [e-pub ahead of print]. Nature https:\/\/doi.org\/10.1038\/s41586-020-2598-9. Accessed July 8, 2020.","DOI":"10.1038\/s41586-020-2598-9"},{"key":"10.1016\/j.jaci.2020.09.020_bib54","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2020.09.020_bib55","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1001\/jama.2020.8259","article-title":"Interpreting diagnostic tests for SARS-CoV-2","volume":"323","author":"Sethuraman","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2020.09.020_bib56","doi-asserted-by":"crossref","unstructured":"Yuan J, Kou S, Liang Y, Zeng J, Pan Y, Liu L. PCR assays turned positive in 25 discharged COVID-19 patients [e-pub ahead of print]. Clin Infect Dis https:\/\/doi.org\/10.1093\/cid\/ciaa398. Accessed August 1, 2020.","DOI":"10.1093\/cid\/ciaa398"},{"key":"10.1016\/j.jaci.2020.09.020_bib57","doi-asserted-by":"crossref","unstructured":"Bullard J, Dust K, Funk D, Strong JE, Alexander D, Garnett L, et\u00a0al. Predicting infectious SARS-CoV-2 from diagnostic samples [e-pub ahead of print]. Clin Infect Dis https:\/\/doi.org\/10.1093\/cid\/ciaa638. Accessed August 1, 2020.","DOI":"10.1093\/cid\/ciaa638"},{"key":"10.1016\/j.jaci.2020.09.020_bib58","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1016\/j.jaip.2020.06.015","article-title":"Persistent viral presence determines the clinical course of the disease in COVID-19","volume":"8","author":"Chang","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2020.09.020_bib59","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/s41591-020-0965-6","article-title":"Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections","volume":"26","author":"Long","year":"2020","journal-title":"Nat Med"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674920313312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674920313312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:25:45Z","timestamp":1789676745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674920313312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0091674920313312"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2020.09.020","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe SARS-CoV-2 disease in the context of a NF-\u03baB2 loss-of-function pathogenic variant","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2020.09.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}